Team:Waterloo/Safety
From 2011.igem.org
(→Safety) |
(→Safety) |
||
Line 48: | Line 48: | ||
==Safety== | ==Safety== | ||
- | The Ribozyme Project is not expected to raise any research, public or environmental safety concerns other than those normally associated with Biosafety Level 2 organisms, such as Escherichia coli (DH5-alpha), which is classified as very low to moderate. The use of this project is primarily reserved for research and laboratory use, therefore, should not purposefully be exposed to the public or environment except after further testing in its specific applications (such as with | + | The Ribozyme Project is not expected to raise any research, public or environmental safety concerns other than those normally associated with Biosafety Level 2 organisms, such as Escherichia coli (DH5-alpha), which is classified as very low to moderate. The use of this project is primarily reserved for research and laboratory use, therefore, should not purposefully be exposed to the public or environment except after further testing in its specific applications (such as with particular fusion proteins). Furthermore, the basis of our project is to establish a self-excising sequence (ribozymes), which should limit the expression of any intervening sequences to the RNA level. If the intervening sequence were something of environmental or public relevance (such as antibiotic resistance), the experimental design indicates that the sequence will be removed and, thus, not expressed. This is a relevant contribution of the design in limiting expression to the RNA level, which eases environmental hazard concern upon the accidental release of a GMO containing this biobrick. Therefore, the new biobrick parts submitted should not raise any safety issues. |
- | '''The necessary facility, equipment and handling | + | '''The necessary facility, equipment and handling procedures associated with Level 2 Biosafety concerns were met:''' |
*Pipetting aids | *Pipetting aids | ||
*Biosafety cabinets where applicable | *Biosafety cabinets where applicable | ||
- | *Laboratory separated from other | + | *Laboratory separated from other activities |
*Biohazard sign | *Biohazard sign | ||
*Proper safety and disposal equipment, including autoclave | *Proper safety and disposal equipment, including autoclave | ||
Line 64: | Line 64: | ||
*All waste was autoclaved before disposal | *All waste was autoclaved before disposal | ||
- | *Researchers practiced aseptic technique and personal | + | *Researchers practiced aseptic technique and personal hygiene and safety precautions |
*Bench surfaces were disinfected with ethanol | *Bench surfaces were disinfected with ethanol | ||
*Procedures likely to generate aerosols are performed in a biosafety cabinet | *Procedures likely to generate aerosols are performed in a biosafety cabinet | ||
*Potentially contaminated waste is separated from general waste | *Potentially contaminated waste is separated from general waste |
Revision as of 16:34, 4 July 2011
You can write a background of your team here. Give us a background of your team, the members, etc. Or tell us more about something of your choosing. | |
Tell us more about your project. Give us background. Use this is the abstract of your project. Be descriptive but concise (1-2 paragraphs) | |
Team Example |
Home | Team | Official Team Profile | Project | Parts Submitted to the Registry | Modeling | Notebook | Safety | Attributions |
---|
Safety
The Ribozyme Project is not expected to raise any research, public or environmental safety concerns other than those normally associated with Biosafety Level 2 organisms, such as Escherichia coli (DH5-alpha), which is classified as very low to moderate. The use of this project is primarily reserved for research and laboratory use, therefore, should not purposefully be exposed to the public or environment except after further testing in its specific applications (such as with particular fusion proteins). Furthermore, the basis of our project is to establish a self-excising sequence (ribozymes), which should limit the expression of any intervening sequences to the RNA level. If the intervening sequence were something of environmental or public relevance (such as antibiotic resistance), the experimental design indicates that the sequence will be removed and, thus, not expressed. This is a relevant contribution of the design in limiting expression to the RNA level, which eases environmental hazard concern upon the accidental release of a GMO containing this biobrick. Therefore, the new biobrick parts submitted should not raise any safety issues.
The necessary facility, equipment and handling procedures associated with Level 2 Biosafety concerns were met:
- Pipetting aids
- Biosafety cabinets where applicable
- Laboratory separated from other activities
- Biohazard sign
- Proper safety and disposal equipment, including autoclave
- Personal protective equipment, worn only in the laboratory
- Screw-capped tubes and bottles
- Plastic disposable pasteur pipettes, when necessary
The necessary precautions regarding recombinant DNA and microorganisms were observed:
- All waste was autoclaved before disposal
- Researchers practiced aseptic technique and personal hygiene and safety precautions
- Bench surfaces were disinfected with ethanol
- Procedures likely to generate aerosols are performed in a biosafety cabinet
- Potentially contaminated waste is separated from general waste